Evidence map›Paper›PMID 20529840›Full record

ArticleThe Journal of biological chemistry2010

A bridging interaction allows calmodulin to activate NO synthase through a bi-modal mechanism.

Jesús Tejero, Mohammad Mahfuzul Haque, Deborah Durra, Dennis J Stuehr

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Energy landscapes and catalysis in nitric-oxide synthase.The Journal of biological chemistry · 2014
    Article
  19. Nitric oxide synthase domain interfaces regulate electron transfer and calmodulin activation.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jesús TejeroDepartment of Pathobiology, Lerner Research Institute, The Cleveland Clinic, Cleveland, Ohio 44195, USA.
Mohammad Mahfuzul Haque
Deborah Durra
Dennis J Stuehr
Cleveland Clinic Lerner College of Medicine · US

Funding

Structural Determinants Of Ceruloplasmin Inflammatory ActivityP01HL076491 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN · 2004 to 2019
$27.3M
CONTROL MECHANISMS OF THE NITRIC OXIDE SYNTHASESR01GM051491 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI STUEHR, DENNIS J · 1994 to 2016
$5.1M
BIOCHEMISTRY OF NITRIC OXIDE SYNTHESISR01CA053914 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI STUEHR, DENNIS J · 1996 to 2010
$3.1M
BIOCHEMISTRY OF MACROPHAGE NITRIC OXIDE SYNTHESISR29CA053914 · NCI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI STUEHR, DENNIS J · 1991 to 1995
–
NCI NIH HHS CA53914NCI NIH HHS R01 CA053914NHLBI NIH HHS HL76491NHLBI NIH HHS P01 HL076491NIGMS NIH HHS GM51491NIGMS NIH HHS R01 GM051491
6 · The paper itself

Abstract

Calmodulin (CaM) activates the nitric-oxide synthases (NOS) by a mechanism that is not completely understood. A recent crystal structure showed that bound CaM engages in a bridging interaction with the NOS FMN subdomain. We investigated its importance in neuronal NOS (nNOS) by mutating the two residues that primarily create the bridging interaction (Arg(752) in the FMN subdomain and Glu(47) in CaM). Mutations designed to completely destroy the bridging interaction prevented bound CaM from increasing electron flux through the FMN subdomain and diminished the FMN-to-heme electron transfer by 90%, whereas mutations that partly preserve the interaction had intermediate effects. The bridging interaction appeared to control FMN subdomain interactions with both its electron donor (NADPH-FAD subdomain) and electron acceptor (heme domain) partner subdomains in nNOS. We conclude that the Arg(752)-Glu(47) bridging interaction is the main feature that enables CaM to activate nNOS. The mechanism is bi-modal and links a single structural aspect of CaM binding to specific changes in nNOS protein conformational and electron transfer properties that are essential for catalysis.

Indexed as

AnimalsBinding SitesCalmodulinCatalysisElectron TransportFlavin-Adenine DinucleotideFlavin MononucleotideHemeMutagenesis, Site-DirectedNADPNitric Oxide SynthaseNitric Oxide Synthase Type IProtein Structure, TertiaryRatsCalmodulinFlavin-Adenine DinucleotideFlavin MononucleotideHemeNADPNitric Oxide SynthaseNitric Oxide Synthase Type I

Identifiers

PMID20529840
PMCPMC2923985
OpenAlexW2029666070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.